Delivery Order SPE2DR25D3103-SPE2DR26F9X59
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,878.13 to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 54 mg on January 6, 2026, with completion scheduled for January 7, 2026. The award was competitively procured with no set-aside designation and utilizes firm fixed-price pricing. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the operating subsidiary of parent company Cencora, Inc., a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,948.54 on July 14, 2025, for the supply of Concerta ER 36 mg tablets (100-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 15, 2025. The contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor...
- The Defense Logistics Agency awarded a delivery order valued at $9,052.36 to AmerisourceBergen Drug Corp for the supply of Concerta ER 54 mg tablets (100-count units) on November 24, 2025, with a completion date of November 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $6,691.96 to AmerisourceBergen Drug Corp for the supply of Concerta ER 27 mg tablets (100 count) on January 9, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price, non-set-aside contract was awarded competitively and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order represents a task order issued under AmerisourceBergen's parent company Cencora,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Concerta ER 54 mg tablets (100-count units) valued at $1,199.34, with a firm fixed price arrangement. The contract was awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Concerta ER Tablets 36mg, with a ceiling value of $1,849.39. This firm fixed-price, non-set-aside contract was awarded on June 6, 2025, with an ultimate completion date of June 9, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order serves as a child contract under the company's existing...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $44,139.22 to AmerisourceBergen Drug Corp for 27mg Concerta ER tablets on June 26, 2025, with completion scheduled for June 27, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with the Defense Logistics Agency. The pharmaceutical products will be delivered to the vendor's...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for 100 tablets of Concerta ER 27 mg, valued at $1,815.45. The award, issued on December 1, 2025, with a completion date of December 2, 2025, represents a firm fixed-price delivery under a non-set-aside competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract executed under the company's...
- The Defense Logistics Agency awarded a $1,580.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Concerta ER 36 mg tablets (100-count units). This contract, with an ultimate completion date of October 20, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The order will be fulfilled from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Concerta ER 54 mg tablets (100-count units) valued at $9,978.49. This non-set-aside, firm fixed-price contract is scheduled for completion by July 22, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9X59Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,957.42 to AmerisourceBergen Drug Corp for the supply of Concerta ER 54 mg tablets (100-unit quantity) on January 14, 2026, with an ultimate completion date of January 15, 2026. This firm fixed-price contract, which involves no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, competes on a full and open basis for such awards. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical supply requirements across multiple therapeutic domains for military treatment facilities and other federal healthcare systems. This specific delivery order for Concerta ER, a commonly prescribed attention-deficit/hyperactivity disorder medication, reflects the company's ongoing role as a trusted supplier of essential medications to the Department of Defense and its healthcare networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 1/13/26 |